4‐Methyl‐5‐(4‐methylphenyl)‐4,5‐dihydrooxazol‐2‐amine (4,4′‐DMAR, 4,4′‐dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-1077|30|3|193-198

ISSN: 0885-6222

Source: Human Psychopharmacology: Clinical And Experimental (Electronic), Vol.30, Iss.3, 2015-05, pp. : 193-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content